Nod1-dependent control of tumor growth

Related Experiment Video

Updated: Aug 13, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Jean da Silva Correia1, Yvonne Miranda, Nikki Austin-Brown

  • 1Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

Proceedings of the National Academy of Sciences of the United States of America
|February 1, 2006
PubMed

Insights

Nod1 protein deficiency promotes estrogen-sensitive breast cancer growth and proliferation. Restoring Nod1 inhibits tumor formation and estrogen-induced cell proliferation, revealing a novel role for Nod1 in cancer.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Nod1 is a cytosolic sensor for bacterial peptidoglycan, crucial for host defense against invasive bacteria.
  • Its role in cancer, particularly in hormone-sensitive tumors, remains largely unexplored.

Purpose of the Study:

  • To investigate the function of Nod1 in the development and progression of estrogen-sensitive breast cancer.
  • To elucidate the molecular pathways linking Nod1 to tumor growth and estrogen responsiveness.

Main Methods:

  • Utilized MCF-7 human breast cancer cell lines in a severe combined immune deficiency (SCID) mouse xenograft model.
  • Assessed tumor formation, estrogen-induced proliferation, and apoptosis in cells with altered Nod1 expression (absence vs. overexpression).

Main Results:

  • Absence of Nod1 in MCF-7 cells correlated with increased tumor growth and heightened sensitivity to estrogen-induced proliferation.
  • Nod1-deficient cells exhibited impaired Nod1-dependent apoptosis.
  • Overexpression of Nod1 inhibited estrogen-dependent tumor growth and reduced estrogen-induced proliferation in vitro.

Conclusions:

  • Nod1 plays a critical role in controlling tumor formation in estrogen-sensitive breast cancer.
  • Nod1 acts as a tumor suppressor by inhibiting estrogen-driven proliferation and promoting apoptosis.
  • Targeting Nod1 pathways may offer a novel therapeutic strategy for estrogen-sensitive breast cancers.

More Related Videos

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...